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TECHNICAL ABSTRACT MFS 28986-I
APPARATUS FOR DIFFUSION CONTROLLED DIALYSIS UNDER
MICROGRAVITY CONDITIONS
The instant invention is directed to an apparatus
for permitting mixing of solutions under microgravity
conditions suitable for growing crystals by dialysis.
The apparatus is primarily adapted for practicing the
dialysis method of protein crystal growth taking advantage
of long duration flight opportunities.
The apparatus 10 comprises a housing 12 within which
a plurality of chambers 20, 22 are formed. A separate
dedicated cylindrical valve 24 is positioned between
the chambers of each pair of chambers. A plug 44 having
an internal cavity 46 for containing a protein solution
closes one of the chambers 20, and a dialysis membrane
46 separates the protein solution from the chamber when
the plug is in place. Another plug 50 closes the other
chamber of each pair. One of the chambers may contain
a wick 56. The housing 12 may have portions 16, 18 of
different lengths such that the chambers of one portion
may be of a different length than the chambers of the
other portion. Thus, the differences in crystal number
and size relative to the rate of approach to critical
supersaturation offered by different path lengths may
be demonstrated and optimized. The wicking 56 permits
diffusive mixing to control the critical approach to
supersaturation via vapor pressure equilibrium.
Precipitating solution and solvent may be placed in one
or both of the chambers of a pair and at microgravity
conditions, the valve 24 may be opened to permit diffusive
mixing to commence.
The novelty of the invention appears to lie in the
use of individual valves so that selected chambers may
be activated sequentially at different times. The
apparatus permits the controlled approach to
supersaturation in the dialysis method or vapor pressure
equilibrium. Additionally, the use of different chamber
lengths in a unitary housing appears to be novel.
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ORIGIN OF THE INVENTION
This invention was made by an employee of the United
States Government and may be manufactured and used by
or for the Government for governmental purposes without
5 the payment of any royalties.
BACKGROUND OF THE INVENTION
(I) FIELD OF THE INVENTION
This invention relates to apparatus for growing
crystals under microgravity conditions, and more
10 particularly to an apparatus for controlling the
precipitant concentration in the dialysis method of
protein crystal growth by diffusive mixing.
(2) DESCRIPTION OF THE PRIOR ART
One of the methods of growing protein crystals
15 or other macromolecules is the dialysis method in which
the protein or other molecular solution is physically
isolated from the precipitating agent by a semi-permeable
membrane. Upon activation, the precipitating agents
diffuse through the membrane and mix with the protein
20 solution. Another method of growing macromolecules is
the vapor diffusion, which decrease the solubility and
concentrate the molecules to be crystallized by means
of solvent evaporation.
Under gravity conditions disruptive convection
5 currents significantly effect the crystal size and
quality. Under microgravity conditions disruptive
convection currents are avoided so that mixing is achieved
by diffusion, thereby allowing a slower approach to
critical supersaturation of the dissolved protein. This
10 reduces the number of nucleation sites created and
increases the size of the crystals which are grown since
additional crystalline material may be deposited about
the nucleii of the crystals formed. Thus, protein
crystals may be grown in microgravity environments to
15 produce crystals which are substantially larger than
those grown under a gravity environment. The crystals
are also of a higher quality and may be used in X-ray
structure determination to permit more precise information
to be obtained about the protein molecules. Additionally,
20 during the actual crystal growth process (irrespective
of the nature of approach to supersaturation), when a
crystal grows in solution under unit gravity, the solution
directly adjacent to the crystal surface becomes depleted
in solute and the surrounding becomes less dense. This
25 results in a growth plume, a convective disturbance called
"solutal convection." In microgravity there is an absence
of solutal convection and the crystal growth process
becomes primarily diffusion limited which results in
larger and more perfect crystals. Such information is
30 of vital importance in advancing the development of new
biotech pharmaceuticals, drugs and medicines.
In Carter et al U.S. Patent No. 4,909,933 there
is proposed an apparatus for carrying out crystal growth
under microgravity conditions by the dialysis method.
The apparatus includes a housing having a number of pairs
of chambers, each pair of chambers having respective
aligned openings separated by a cylindrical valve member
5 common to the other pairs of chambers. The valve member
may be rotated to simultaneously open or close
communication between each pair of chambers of all of
the pairs of chambers. This apparatus thus may be
employed when a number of solutions are to be mixed at
10 one time. Additionally, in accordance with the aforesaid
patent, when carrying out dialysis for protein
crystallization one of the chambers was filled with
solution and sealed while dialysis buttons or membrane
sacks had to be placed within the other chamber which
15 was then sealed by a cap having a puncturable resealable
elastic material. A second solution may be introduced
into the chamber by a syringe needle which punctures
the elastic material which thereafter reseals itself.
In proposed long duration space flights, a
20 substantial number of experiments concerning protein
crystallization are proposed for obtaining crystals of
various proteins. It is thus desirable that
crystallization by the dialysis method take advantage
of diffusive mixing process to control the approach to
25 supersaturation and that more control be provided over
the dialysis or diffusive mixing processes performed
during such microgravity environments so that the
opportunities for growing such crystals may be custom
tailored.
30 SUMMARY OF THE INVENTION
Consequently, it is a primary object of the present
invention to provide an apparatus for growing protein
crystals under controlled conditions in microgravity
3
environments.
It is another object of the present invention to
provide an apparatus for growing protein crystals under
microgravity conditions wherein protein crystals may
5 be grown within a plurality of pairs of chambers, the
growing process being initiated or activated sequentially
at different intervals in each individual pair of
chambers.
It is a further object of the present invention
10 to provide apparatus for performing the dialysis method
of protein crystallization under microgravity conditions
wherein a protein solution may be contained within a
cap having a dialysis membrane and which closes one of
a pair of chambers, there being a plurality of pairs
15 of chambers with the chambers of each pair separated
by a dedicated valve member that may be selectively
actuated to communicate the respective pair of chambers
and permit one or more precipitating agents to diffuse
through the membrane and mix with the protein solution.
20 Consequently, the present invention provides an
apparatus for implementing crystal growth by allowing
mixing of solutions under microgravity conditions, the
apparatus comprising a housing having a plurality of
pairs of chambers, the chambers of each pair being
25 disposed for communication with each other through a
valve which may open or close such communication. Each
pair of chambers has a separate valve which is selectively
controlled so that the individual pairs of chambers may
be activated sequentially at selected intervals to take
30 advantage of long duration flight opportunities. Protein
solution, or other potential crystal growth solution,
may be located within a small cavity in a cap which closes
one of the chambers of a pair, the cavity in the cap
4
being closed by a dialysis membrane. Precursor solutions
or precipitating agents may be placed in one or both
of the chambers and the chambers sealed. When the
apparatus is in a microgravity environment, each valve
5 may be selectively rotated at an appropriate time.
Optimum conditions for each dialysis experiment may be
customized by varying the length of the chambers in
selected pairs thereof. Conversely, valves of different
orifice diameters may be utilized to control the diffusive
10 mixing rate, thereby decreasing the overall length
requirements of the device while achieving the same
objectives. Additionally, wicking material may be placed
in one or both of the chambers of a pair to control the
diffusive mixing and thereby control the critical approach
15 to supersaturation by vapor pressure equalization. The
wicking may also be placed in or near the valve orifice
for controlling the propagation of turbulent mixing
produced when the valve is opened during activation.
The apparatus may be utilized to perform liquid-liquid
20 diffusion experiments in substantially any type of crystal
growth application.
BRIEF DESCRIPTION OF THE DRAWINGS
The particular features and advantages of the
invention as well as other objects will become apparent
25 from the following description taken in connection with
the accompanying drawings in which:
Fig. I is a fragmentary perspective view illustrating
an apparatus incorporating the principles of the present
invention and illustrating an embodiment depicting a
30 series of chambers having two different lengths;
Fig. 2 is a cross sectional view taken substantially
along line 2-2 of Fig. I;
Fig. 3 is a fragmentary cross sectional view similar
510
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to Fig. 2, but illustrating a wicking material disposed
in one of the chambers;
Fig. 4 is an elevational view of one of the valves;
and
Fig. 5 is an enlarged view of the protein solution
containing cap illustrated in Fig. 2.
DESCRIPTION OF THE PREFERRED EMBODIMENT
Referring now to the drawings, apparatus 10
constructed in accordance with the present invention
for carrying out protein crystallization by dialysis
and other chemical syntheses utilizing diffusive mixing,
comprises a housing 12 which may be constructed from
lightweight non-corrosive chemically inert materials,
such as durable plastics or from stainless steel or other
metal alloys. Although not illustrated, it may desirable
to construct the housing out of a clear plastic material
such as PLEXIGLASS (methyl acrylate plastic), polyethylene
or TEFLON (polytetrafluorethylene) so that it may be
possible to view the ongoing process visually. Otherwise,
it may be desirable that a number of windows (not
illustrated) above all or some of the chambers may be
utilized to view and monitor the reactions. The housing
12 preferably has a substantially rectangular
configuration, and may have stepped down portions such
as illustrated at 14 such that at least two different
length portions 16, 18 may be formed for reasons
hereinafter made clear.
Formed in the housing 12 are a plurality of pairs
of elongated cylindrical chambers 20, 22 extending through
the housing, and since each pair of chambers is
substantially identical, except for variations in the
length of certain of the chambers, only one pair is
illustrated in Fig. 2. Disposed between each pair of
chambers is a respective rotary valve member 24 comprising
a cylindrical body member 26 with its axis of rotation
extending transverse to the axes of the chambers and
having an internal orifice or passageway 28 extending
5 diametrically therethrough and adapted to be selectively
aligned with the respective chambers 20, 22. The body
of each valve member 24 includes a pair of O-rings 30,
one above and one below the passageway 28, to provide
a leak-free seal between the valve and the exterior of
10 the housing. A lock ring in the form of a split ring
or the like 32 secures the valve within the housing,
while a disk-shaped cap 34 is disposed at one end of
the valve body, i.e., the upper end, the exterior face
of the cap being substantially planar with the upper
15 surface 36 of the housing 12. A slot 38 or other
indentation formed in the upper surface 36 of the cap
provides a means for rotating the cap and thus the valve
to selectively align the passageway 28 with the chambers
20, 22 to provide communication between the chambers
20 as illustrated in Fig. 2 or to close such communication.
Each of the chambers 20, 22 open onto a respective
enlarged threaded or tapped bore 40, 42 at the end of
the chambers remote from the valve member 24. Threaded
into the bore 40 to close the chamber 20 is a plug 44
25 having an internal cavity 46 adjacent the end of the
plug which is received within the bore 40. A semi-
permeable dialysis membrane 48 covers or closes the cavity
46 so that a protein solution may be placed within the
cavity covered by the membrane 48 and be acted upon by
30 one or more precipitating agents which diffuse through
the membrane. A similar plug 50, albeit without the
protein solution cavity and dialysis membrane, is threaded
into the bore 42 of the chamber 22. Each of the plugs
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44, 50 includes a respective O-ring 52, 54 to preclude
leakage from the respective chamber. Preferably, at
least the cap 50 may be formed from a durable elastic
material which permits a needle syringe to pierce the
cap to remove air from the chambers and may permit filling
of one or more of the chambers with fluids while the
cap is in place. The cap 50 may thus contain a TEFLON
(polytetrafluorethylene) coated silicon rubber septum.
Since there is a separate valve for each pair of
chambers, dialysis may be initiated in one pair of
chambers independently of the other pairs of chambers.
Thus, dialysis may be activated sequentially at different
times to take advantage of long duration flight
opportunities. A precipitating solution and solvent
may be placed in the chambers 22 with each of the
respective valves closed, and the various valves may
be opened at specified times to permit the solution to
enter the chamber 20 and diffuse through the membrane
48. If two separate solutions are to be used, one may
be received into chamber 20 with the valve closed prior
to closing the chamber by the plug 44. After the chamber
is closed by the plug, the second solution may fill
chamber 22 and it may be closed by the plug 50, or the
first solution may fill chamber 22 when the valve is
closed and the second solution may be injected into the
chamber 22 after the valve is opened and the first
solution enters the chamber 20. A substantial number
of possible modes of operation are thus available to
a researcher with apparatus constructed in accordance
with the present invention. Moreover, rather than placing
the protein within the cavity 46, the protein may be
contained within a variety of accepted forms, e.g. within
a dialysis button, syringe, on a glass slip or the like.
8
Also the plug 44 may contain protein without using a
membrane 48.
Additionally, by constructing the apparatus with
at least two portions, 16, 18, having different chamber
5 lengths, the differences in crystal number and size
relative to the rate of approach to critical
supersaturation may be demonstrated by the different
path lengths. A housing having three or more different
chamber lengths in three different length portions would
10 of course further demonstrate additional rates of
approach.
Moreover, as illustrated in Fig. 3, a wick 56
comprising polysulphone, high molecular weight
polyethylene, or similar porous wick material either
15 entirely within chamber 20 or a portion thereof, may
permit diffusive mixing to be used to control the critical
approach to supersaturation by vapor pressure equilibrium,
as, for example, in the standard "hanging drop" technique.
The wicking provides the required surface area for the
20 vapor equalization process to occur during the growth
of the protein crystals. When placed in or near the
valve orifice, the wicking may also be used to control
the propagation of turbulent mixing produced when the
valve is opened during activation. The wick may be of
25 various shapes, including a donut or annulus shape.
Accordingly, apparatus constructed in accordance
with the present invention provides a controlled approach
to supersaturation in the dialysis method of
crystallization. It permits individual pairs of chambers
30 to be activated sequentially at different times to take
advantage of long duration flight opportunities and
provides a simple inexpensive approach to control
supersaturation in microgravity environments. Optimum
I0
conditions for each crystallization can be customized
by varying the chamber lengths or the valve orifice
diameters.
Numerous alterations of the structure herein
disclosed will suggest themselves to those skilled in
the art. However, it is to be understood that the present
disclosure relates to the preferred embodiment of the
invention which is for purposes of illustration only
and not to be construed as a limitation of the invention.
All such modifications which do not depart from the spirit
of the invention are intended to be included within the
scope of the appended claims.
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APPARATUS FOR DIFFUSION CONTROLLED DIALYSIS UNDER
MICROGRAVITY CONDITIONS
ABSTRACT OF THE DISCLOSURE
Apparatus for implementing crystal growth by allowing
mixing of solutions under microgravity conditions includes
a housing within which a number of pairs of chambers
5
are formed. The chambers of each pair are aligned and
a rotary valve is positioned between the chambers of
each pair. When the valve is in a first position one
chamber of each pair may communicate with the other
chamber. A separate valve is provided for each pair
10 of chambers so that each pair of chambers may be activated
independently of the others and sequentially at selected
intervals. Protein solution may be located within a
small cavity in a cap which closes one of the chambers
of a pair, and the cavity in the cap is closed by a
15 dialysis membrane. The length of certain pairs of
chambers may differ from the length of other pairs of
chambers to optimize conditions for various dialysis
productions, and wicking material may be incorporated
into selected chambers for controlling the critical
20 approach to supersaturation.
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